July 12, 2011
MEDIA STATEMENT
Use of antipyretics to reduce flu-related fever
The New Zealand Self-Medication Industry Association (SMI), the industry body representing non-prescription consumer
healthcare products, said today it was aware of a recommendation by the Wellington-based Medical Research Institute that
antipyretics, such as paracetamol, ibuprofen and aspirin, not be used to reduce flu-related fever.
“We have only just received this information and, as the Institute itself said, there was insufficient evidence for the
Ministry of Health to change its current position on these products. It’s important people do not overreact and stop
using antipyretics altogether.
Paracetamol and ibuprofen, for example, are well recognized for the relief of pain,” commented SMI executive director
Tim Roper.
“Fever management guidelines highlight that it is important to treat the patient and not the thermometer - SMI and its
members endorse this approach. We are confident that if this approach is used, that these medicines can be used safely.
“Nevertheless, our members welcome the opportunity to work with Medsafe to discuss any matters that may arise, after the
Ministry has reviewed the new information.”
ends